يعرض 1 - 10 نتائج من 17 نتيجة بحث عن '"Lovely Goyal"', وقت الاستعلام: 0.70s تنقيح النتائج
  1. 1
    Prophylactic corticosteroid use in patients receiving axicabtagene ciloleucel for large B-cell lymphoma

    المؤلفون: Olalekan O. Oluwole, Umar Farooq, Lovely Goyal, Patrick J. Stiff, Yi Lin, Yan Zheng, John M. Timmerman, Lisa Johnson, Krimo Bouabdallah, Peter A. McSweeney, Catherine Thieblemont, Marie José Kersten, Javier Munoz, John M. Rossi, Julie M. Vose, Caron A. Jacobson, Jeff McLeroy, Zahid Bashir, Nancy L. Bartlett, Sophie de Guibert, Andre Goy, Irit Avivi, Jenny J. Kim, Tom van Meerten, Dimitrios Tzachanis, Abhinav Deol, Monique C. Minnema

    المساهمون: Clinical Haematology, AII - Cancer immunology, CCA - Cancer Treatment and Quality of Life, Stem Cell Aging Leukemia and Lymphoma (SALL)

    المصدر: British journal of haematology, vol 194, iss 4
    British Journal of Haematology
    British journal of haematology, 194(4), 690-700. Wiley-Blackwell
    British Journal of Haematology, 194(4), 690-700. Wiley

    مصطلحات موضوعية: Male, Lymphoma, medicine.medical_treatment, T-Lymphocytes, Adoptive, large B‐cell lymphoma, Cardiorespiratory Medicine and Haematology, Immunotherapy, Adoptive, THERAPY, Dexamethasone, corticosteroids, chemistry.chemical_compound, Antineoplastic Agents, Immunological, axi‐cel, Adrenal Cortex Hormones, 80 and over, Cancer, Aged, 80 and over, chimaeric antigen receptor‐T cell, Receptors, Chimeric Antigen, Incidence (epidemiology), Hematology, Middle Aged, Haematological malignancy – Clinical, Diffuse, Cytokine release syndrome, chimaeric antigen receptor-T cell, Immunological, 6.1 Pharmaceuticals, Cohort, Corticosteroid, Steroids, Female, Lymphoma, Large B-Cell, Diffuse, prophylaxis, Immunotherapy, Research Paper, Adult, medicine.medical_specialty, medicine.drug_class, Immunology, Antineoplastic Agents, Tocilizumab, Rare Diseases, Clinical Research, Internal medicine, medicine, MANAGEMENT, axi-cel, Large B-Cell, Humans, Aged, Chemotherapy, Biological Products, large B-cell lymphoma, business.industry, CYTOKINE RELEASE SYNDROME, Evaluation of treatments and therapeutic interventions, cytokine release syndrome, Leukapheresis, medicine.disease, chemistry, PROPENSITY-SCORE, business

    وصف الملف: application/pdf

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25036bc6aeb6beaaba44629eb3f65d3eTest
    https://escholarship.org/uc/item/11d048rnTest


    أضف إلى المفضلة
  2. 2
    KTE-X19 anti-CD19 CAR T-cell therapy in adult relapsed/refractory acute lymphoblastic leukemia: ZUMA-3 phase 1 results

    المؤلفون: Daniel J. DeAngelo, William G. Wierda, Remus Vezan, Michael R. Bishop, Lovely Goyal, Gary J. Schiller, Olalekan O. Oluwole, Rajul K. Jain, John M. Rossi, Adriana K. Malone, Martha Arellano, Armin Ghobadi, Maria R. Baer, Ryan D. Cassaday, John M. Pagel, Houston Holmes, Tong Shen, William B. Donnellan, Adrian Bot, Yi Lin, Raya Mawad, Mehrdad Abedi, Aaron C Logan, Kristen M. O'Dwyer, Bijal D. Shah, Januario E. Castro, Jae H. Park

    المصدر: Blood

    مصطلحات موضوعية: 0301 basic medicine, Adult, Male, medicine.medical_specialty, Neoplasm, Residual, Adolescent, Clinical Trials and Observations, Immunology, Antigens, CD19, Biochemistry, Gastroenterology, Immunotherapy, Adoptive, Disease-Free Survival, 03 medical and health sciences, chemistry.chemical_compound, Young Adult, 0302 clinical medicine, Tocilizumab, Refractory, Internal medicine, medicine, Clinical endpoint, Biomarkers, Tumor, Humans, Young adult, Adverse effect, Aged, Cell Proliferation, Receptors, Chimeric Antigen, Dose-Response Relationship, Drug, business.industry, Cell Biology, Hematology, Middle Aged, Precursor Cell Lymphoblastic Leukemia-Lymphoma, medicine.disease, Minimal residual disease, Confidence interval, Cytokine release syndrome, 030104 developmental biology, Treatment Outcome, chemistry, 030220 oncology & carcinogenesis, Female, Inflammation Mediators, business, Cytokine Release Syndrome

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d4d5ee12644278b6fe8c95c84ae2ccaTest
    https://pubmed.ncbi.nlm.nih.gov/33827116Test


    أضف إلى المفضلة
  3. 3
    ALPHA Study: ALLO-501 Produced Deep and Durable Responses in Patients with Relapsed/Refractory Non-Hodgkin's Lymphoma Comparable to Autologous CAR T

    المؤلفون: Arun Balakumaran, Lynn Loomis-Navale, Don A. Stevens, Anh T. Nguyen, Rajneesh Nath, Chu Ri Shin, Lovely Goyal, Frederick L. Locke, Sattva S. Neelapu, Shahbaz A. Malik, Matthew J. Frank, Michael Tees, Javier Munoz, David B. Miklos

    المصدر: Blood. 138:3878-3878

    مصطلحات موضوعية: medicine.medical_specialty, business.industry, Immunology, Alpha (ethology), Cell Biology, Hematology, medicine.disease, Biochemistry, Gastroenterology, Non-Hodgkin's lymphoma, Internal medicine, Relapsed refractory, medicine, In patient, Car t cells, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::0ab8ec1836df4bb8a170b2db977f0da8Test
    https://doi.org/10.1182/blood-2021-146038Test


    أضف إلى المفضلة
  4. 4
    Primary Analysis of ZUMA-5: A Phase 2 Study of Axicabtagene Ciloleucel (Axi-Cel) in Patients (Pts) with Relapsed/Refractory (R/R) Indolent Non-Hodgkin Lymphoma (iNHL)

    المؤلفون: Ran Reshef, Olalekan O. Oluwole, John M. Rossi, Remus Vezan, Mauro P. Avanzi, Yin Yang, Wayne R. Godfrey, Vicki Plaks, David G. Maloney, Jennifer Lee, Alison R. Sehgal, Lovely Goyal, Sven de Vos, Caron A. Jacobson, Javier Munoz, Pashna N. Munshi, Ibrahim Yakoub-Agha, Lori A. Leslie, Henry C. Fung, Basem M. William, Julio C. Chavez, Gilles Salles, Sattva S. Neelapu, Carla Casulo, Joseph D. Rosenblatt

    المصدر: Transplantation and Cellular Therapy. 27:S67-S68

    مصطلحات موضوعية: Oncology, Transplantation, medicine.medical_specialty, business.industry, Phases of clinical research, Cell Biology, Hematology, Internal medicine, Relapsed refractory, Indolent Non-Hodgkin Lymphoma, Molecular Medicine, Immunology and Allergy, Medicine, In patient, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::58be237eea939e32404890b80bbc4992Test
    https://doi.org/10.1016/s2666-6367Test(21)00095-6


    أضف إلى المفضلة
  5. 5
    Interim Analysis (IA) of ZUMA-12: A Phase 2 Study of Axicabtagene Ciloleucel (Axi-Cel) As First-Line Therapy in Patients (Pts) with High-Risk Large B Cell Lymphoma (LBCL)

    المؤلفون: Olalekan O. Oluwole, Sattva S. Neelapu, Jun Kawashima, Matthew L. Ulrickson, Lovely Goyal, Yin Yang, Catherine Thieblemont, Sven de Vos, Alex F. Herrera, Chaitra S. Ujjani, Yi Lin, Natasha Kekre, Michael Dickinson, Julio C. Chavez, Francesca Milletti, Peter A. Riedell

    المصدر: Transplantation and Cellular Therapy. 27:S3-S4

    مصطلحات موضوعية: Oncology, Transplantation, medicine.medical_specialty, business.industry, Phases of clinical research, Cell Biology, Hematology, medicine.disease, Interim analysis, First line therapy, Internal medicine, medicine, Molecular Medicine, Immunology and Allergy, In patient, B-cell lymphoma, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::d3f1bae57badbc5270dfa74ca9e2e325Test
    https://doi.org/10.1016/s2666-6367Test(21)00030-0


    أضف إلى المفضلة
  6. 6
    Outcomes of Patients (Pts) in ZUMA-9, a Multicenter, Open-Label Study of Axicabtagene Ciloleucel (Axi-Cel) in Relapsed/Refractory Large B Cell Lymphoma (R/R LBCL) for Expanded Access and Commercial Out-of-Specification (OOS) Product

    المؤلفون: Peter A. Riedell, John M. Rossi, Julie M. Vose, Lovely Goyal, Lazaros J. Lekakis, Sattva S. Neelapu, Jun Kawashima, David G. Maloney, Yi Lin, Samantha Jaglowski, Miguel-Angel Perales, Jenny J. Kim, Yin Yang, David B. Miklos, Caron A. Jacobson, Lihua E. Budde, Frederick L. Locke

    المصدر: Blood. 136:2-3

    مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Immunology, Cell Biology, Hematology, medicine.disease, Biochemistry, Open label study, Internal medicine, Product (mathematics), Expanded access, Relapsed refractory, medicine, business, B-cell lymphoma

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::8b207b15915c95a2aa18983be6bd2bedTest
    https://doi.org/10.1182/blood-2020-136136Test


    أضف إلى المفضلة
  7. 7
    Primary Analysis of Zuma-5: A Phase 2 Study of Axicabtagene Ciloleucel (Axi-Cel) in Patients with Relapsed/Refractory (R/R) Indolent Non-Hodgkin Lymphoma (iNHL)

    المؤلفون: Lovely Goyal, Ran Reshef, Olalekan O. Oluwole, Remus Vezan, Basem M. William, Yin Yang, Javier Munoz, Alison R. Sehgal, Sven de Vos, Mauro P. Avanzi, Julio C. Chavez, Jennifer Lee, Carla Casulo, David G. Maloney, Sattva S. Neelapu, Henry C.H. Fung, Pashna N. Munshi, Caron A. Jacobson, Gilles Salles, Lori A. Leslie, Vicki Plaks, Wayne R. Godfrey, Ibrahim Yakoub-Agha, Joseph D. Rosenblatt, John M. Rossi

    المصدر: Blood. 136:40-41

    مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Immunology, Phases of clinical research, Cell Biology, Hematology, Biochemistry, Internal medicine, Relapsed refractory, medicine, Indolent Non-Hodgkin Lymphoma, In patient, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::50e0d5a2de85d9b61f0a590cd9cead93Test
    https://doi.org/10.1182/blood-2020-136834Test


    أضف إلى المفضلة
  8. 8
    Abstract CT036: Axicabtagene ciloleucel (axi-cel) product attributes and immune biomarkers associated with clinical outcomes in patients (pts) with relapsed/refractory (R/R) indolent non-Hodgkin lymphoma (iNHL) in ZUMA-5

    المؤلفون: Alison R. Sehgal, John M. Rossi, Shruti Salunkhe, Sattva S. Neelapu, Mauro P. Avanzi, Justin Chou, Adrian Bot, Vicki Plaks, Lovely Goyal, Caron A. Jacobson, Wangshu Zhang, Julio C. Chavez

    المصدر: Cancer Research. 81:CT036-CT036

    مصطلحات موضوعية: Cancer Research, medicine.medical_specialty, business.industry, Follicular lymphoma, Phases of clinical research, Cancer, medicine.disease, Gastroenterology, Lymphoma, Cytokine release syndrome, Oncology, Internal medicine, Indolent Non-Hodgkin Lymphoma, Medicine, CCL17, CXCL10, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::4383659abecdb91e862907663a240699Test
    https://doi.org/10.1158/1538-7445.am2021-ct036Test


    أضف إلى المفضلة
  9. 9
    Updated outcomes with axicabtagene ciloleucel (axi-cel) retreatment (reTx) in patients (pts) with relapsed/refractory (R/R) indolent non-Hodgkin lymphoma (iNHL) in ZUMA-5

    المؤلفون: Julio C. Chavez, Basem M. William, Lovely Goyal, Sattva S. Neelapu, Gilles Salles, David G. Maloney, Mauro P. Avanzi, Yin Yang, Caron A. Jacobson, Alison R. Sehgal, Vicki Plaks, Justin Chou

    المصدر: Journal of Clinical Oncology. 39:7548-7548

    مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, business.industry, Marginal zone lymphoma, Follicular lymphoma, Phases of clinical research, medicine.disease, Internal medicine, Relapsed refractory, Indolent Non-Hodgkin Lymphoma, Medicine, In patient, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::4eb810e07891735b1e0de00b69c728a5Test
    https://doi.org/10.1200/jco.2021.39.15_suppl.7548Test


    أضف إلى المفضلة
  10. 10
    Outcomes of Patients (Pts) in ZUMA-9, a Multicenter, Open-Label Study of Axicabtagene Ciloleucel (Axi-Cel) in Relapsed/Refractory Large B Cell Lymphoma (R/R LBCL) for Expanded Access (EA) and Commercial out-of-Specification (OOS) Product

    المؤلفون: Miguel-Angel Perales, Sattva S. Neelapu, Lovely Goyal, John M. Rossi, Julie M. Vose, Jenny J. Kim, David B. Miklos, Frederick L. Locke, Lihua E. Budde, Yi Lin, Lazaros J. Lekakis, David G. Maloney, Samantha Jaglowski, Jun Kawashima, Peter A. Riedell, Yin Yang, Caron A. Jacobson

    المصدر: Transplantation and Cellular Therapy. 27:S408

    مصطلحات موضوعية: Oncology, Transplantation, medicine.medical_specialty, business.industry, Cell Biology, Hematology, medicine.disease, Open label study, Expanded access, Internal medicine, Product (mathematics), Relapsed refractory, medicine, Molecular Medicine, Immunology and Allergy, business, B-cell lymphoma

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::03c9d4291482634792f70e30541f5ca9Test
    https://doi.org/10.1016/s2666-6367Test(21)00524-8


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث